| Myriad Pharmaceuticals, Inc. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110111025 | High Drug Load Formulations and Dosage Forms - The invention relates to high drug load formulations containing (R)-2-(2-fluoro-4-biphenylyl)propionic acid as an active pharmaceutical ingredient. | 05-12-2011 |
| 20100292255 | Therapeutic Compounds and Their Use in Treating Diseases and Disorders - The invention provides novel therapeutic compounds, pharmaceutical compositions comprising these compounds, and methods for using these compounds and compositions to treat diseases and disorders, such as cancer. | 11-18-2010 |
| 20100261739 | Method of Treating Non-Small Cell Lung Cancer - A method of treating non-small cell lung cancer (NSCLC), and especially NSCLC that has metastasized to brain is disclosed. | 10-14-2010 |
| 20100240630 | COMPOUNDS AND THERAPEUTIC USES THEREOF - The invention relates to compounds, pharmaceutical compositions and methods useful for treating viral infection. | 09-23-2010 |
| 20100216862 | Pyrrole Derivatives As Therapeutic Compounds - Novel pyrrole derivatives are disclosed as Aβ | 08-26-2010 |
| 20100216751 | Liquid Bevirimat Dosage Forms for Oral Administration - The present application discloses and claims liquid pharmaceutical compositions comprising bevirimat dimeglumine as a drug substance, methods of treatment comprising administering such compositions to a subject in need thereof, and the use of such compositions in the manufacture of medicaments. | 08-26-2010 |
| 20100184975 | COMPOUNDS FOR ALZHEIMBER'S DISEASE - The invention provides novel compounds useful for the treatment of neurodegenerative disorders including Alzheimer's disease and dementia. The compounds have a substituents chosen from -L-C(═O)OH, -L-CH═CHC(═O)OH, -L-C(═O)NH | 07-22-2010 |
| 20100137342 | METHODS FOR TREATING VASCULAR DISRUPTION DISORDERS - Disclosed is (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride effective as a vascular disrupting agent. (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride is useful in the treatment of a variety of clinical conditions that are responsive to disruption of the vascular system, and in particular to its use in treating vascular macular degeneration. | 06-03-2010 |
| 20100093773 | METHODS OF TREATING CANCER - Disclosed is (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride effective as a vascular disrupting agent. (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride is useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs, and in particular to its use in treating cancer. | 04-15-2010 |
| 20100087458 | METHOD OF TREATING MELANOMA - Disclosed is (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride effective as a cytotoxic agent. (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride is useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs, and in particular to its use in treating melanoma. | 04-08-2010 |
| 20100087457 | DOSAGES AND METHODS FOR THE TREATMENT OF CANCER - In general, the invention relates to a pharmaceutical dose having (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride as the active ingredient that upon administration to a subject provides a C | 04-08-2010 |
| 20100068197 | PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF - Disclosed are compounds of Formula I effective as cytotoxic agents. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs. | 03-18-2010 |
